5.1 Brevetto
 Distribuzione geografica
Continente #
EU - Europa 11.530
NA - Nord America 9.261
AS - Asia 4.990
SA - Sud America 237
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 59
OC - Oceania 9
Totale 26.247
Nazione #
US - Stati Uniti d'America 9.157
NL - Olanda 3.816
GB - Regno Unito 2.353
CN - Cina 2.150
IT - Italia 1.549
SG - Singapore 1.134
UA - Ucraina 887
SE - Svezia 835
JP - Giappone 673
DE - Germania 499
TR - Turchia 492
FR - Francia 370
RU - Federazione Russa 312
FI - Finlandia 309
VN - Vietnam 223
IE - Irlanda 166
BR - Brasile 163
AT - Austria 130
BE - Belgio 100
PL - Polonia 79
IN - India 74
CA - Canada 68
EU - Europa 61
KR - Corea 56
BD - Bangladesh 43
ES - Italia 32
HK - Hong Kong 29
AR - Argentina 28
RO - Romania 22
MX - Messico 19
ZA - Sudafrica 14
CO - Colombia 13
IQ - Iraq 13
KE - Kenya 13
ID - Indonesia 11
LT - Lituania 11
VE - Venezuela 11
EC - Ecuador 10
MA - Marocco 10
PK - Pakistan 10
PT - Portogallo 10
CH - Svizzera 9
SA - Arabia Saudita 9
JO - Giordania 8
TG - Togo 8
AU - Australia 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
MY - Malesia 6
IR - Iran 5
AL - Albania 4
BG - Bulgaria 4
DK - Danimarca 4
EE - Estonia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
HR - Croazia 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
BO - Bolivia 2
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
Totale 26.133
Città #
Amsterdam 3.793
Southend 2.184
Dallas 1.913
Chandler 823
Jacksonville 684
San Jose 668
Ann Arbor 650
Ashburn 610
Singapore 539
Nanjing 491
Houston 391
Woodbridge 366
Izmir 364
Urbino 333
Beijing 331
Boardman 185
Nanchang 174
Munich 165
Dublin 153
Wilmington 148
New York 147
Helsinki 140
Düsseldorf 136
Vienna 128
San Mateo 122
Dong Ket 106
Princeton 104
Lauterbourg 102
Council Bluffs 100
Des Moines 100
Brussels 98
Los Angeles 98
Orciano Di Pesaro 92
Kunming 90
Cambridge 83
Jiaxing 74
Shenyang 69
Tianjin 69
Fairfield 67
Istanbul 66
Santa Clara 66
Hebei 65
Milan 64
Changsha 62
Moscow 60
Velikiy Novgorod 57
Seongnam 52
Kraków 50
Shanghai 47
Ho Chi Minh City 41
Hangzhou 40
Buffalo 38
Rome 38
Bremen 36
Lanzhou 33
Frankfurt am Main 32
Paris 32
Seattle 32
Jinan 31
Tokyo 31
Toronto 31
Venice 29
Ancona 27
Hanoi 26
Wuppertal 26
Changchun 23
San Francisco 23
The Dalles 23
Turku 23
Warsaw 23
Hong Kong 22
Dearborn 21
Guangzhou 20
Montreal 20
Stockholm 20
Brooklyn 19
Civitanova Marche 18
West Jordan 18
Atlanta 17
Chicago 17
Ningbo 16
Phoenix 16
Zhengzhou 16
Bologna 15
Florence 15
London 15
Poplar 15
Denver 14
Nuremberg 14
Orem 14
Redwood City 14
Boston 13
Manchester 13
São Paulo 13
Chennai 12
Dormagen 12
Ascoli Piceno 11
Johannesburg 11
Macerata 11
Mexico City 11
Totale 18.580
Nome #
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 3.156
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 3.154
Derivative of [(3-hydroxy-4-pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs 357
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 335
Device and single-molecule analysis method by means of detection of the collisions of a target molecule on functionalized nanopores 327
DEVICE FOR EMULATING ENERGY SOURCES USED TO POWER EMBEDDED SYSTEMS/DEVICES 324
Pharmaceutical composition of [(3-​hydroxy-​4 -​pyron-​2-​yl) methyl] -​amine derivatives and DNA demethylating agents and their use as anti-​neoplastic drugs 295
Microfluidic-formulated leukosome compositions and fabrication methods therefor 287
METHOD FOR PRODUCING OPTICALLY ACTIVE 1,2-DIAMINE COMPOUND AND OPTICALLY ACTIVE NIOBIUM CATALYST 260
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 259
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell'aria 254
2,4,5-TRISUBSTITUTED OXAZOLES 250
SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED 248
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 247
Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment 245
Corpo cavo di Sonda geotermica e Sonda geotermica 239
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 238
Drug delivery systems 238
Acyclovir prodrug and its use in pharmaceutical compositions 237
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 237
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 236
Method And Relative Test Structure For Measuring The Coupling Capacitance Between Two Interconnect Lines 229
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 228
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 228
Uso del Sulodexide per la riduzione delle metalloproteasi di matrice 228
Attrezzo ginnico sportivo 226
Processo per la preparazione di esteri degli acidi 2-aril-alcanoici 225
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 222
Control system of acoustic echo cancellers for telephone terminals with handset or handsfree 222
5-fluorocitosina come agente antibatterico 221
Peripherally Restricted FAAH Inhibitors 218
Biomimetic proteolipid vesicle compositions and uses thereof 216
Production of triterpenic acids by in vitro culture of calluses deriving from the pulp of red sentinel apples 216
Delivery of Contrasting Agents for Magnetic Resonance Imaging 215
Procedimento perfezionato per la riduzione di composti organici mediante l'impiego di idruro di magnesio 213
Pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation 212
Filtro per l’equalizzazione e/o la Linearizzazione sistemi non lineari 209
A process for the preparation of monosialoganglioside by autolysis of cattle brain. 209
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell’aria 208
DEVICE FOR GENERATING MICRO- AND NANO-FLOW MOBILE PHASE GRADIENTS FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 205
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 205
Procedimento per la preparazione di monosialoganglioside 204
“Tretamerous derivative of indole-3-carbinol with anticancer activity and method of synthesis of said derivative “ 203
Procedimento per la preparazione di biopolimeri 199
Procedimento per ottenere una sostanza antiossidante da peci fenoliche. 198
Nanoparticles for delivery of a pharmacologically active agent 196
Procedimento per la produzione di esteri metilici di acidi grassi per reazione di trigliceridi di origine naturale con alcol metilico in presenza di resine 193
Nutritional supplement, especially for dairy products, comprises leptin. 192
5-fluorocitosina come agente antibatterico 192
AMINOPYRROLE DERIVATIVES 189
Use of microparticles for antigen delivery 188
DERIVATIVES OF [(3-HYDROXY-4-PYRON-2-YL)-METHYL]-AMINE AND USE THEREOF AS ANTI-NEOPLASTIC DRUGS 186
A process for obtaining chemically defined and reproducible polydeoxyribonucleotides. 185
DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS. 185
Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments 185
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 184
Derivati 2-Acilamminoalchilindolici come Antagonisti/Agonisti Parziali della Melatonina 180
Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor ant their use as medicaments 178
Preparation of glutathione derivatives as antiviral agents 176
PYRROLO[3,4-d]PYRIMIDINES 175
ANTIINFLAMMATORY OXAZOLES 172
PYRROLO[3,4-d]PYRIMIDINES 171
“ ,Processo de producao de antioxidante alquilado, obtido a partir de fenois, cresois e preferencialmente do cardanol hidrogenado, 3-pentadecilfenol (3-PDP) aplicavel como aditivo em combustiveis e lubrificantes. “ 170
PROCEDIMENTO DI SELEZIONE AUTOMATICA DI FOTOGRAFIE DIGITALI DA UN ARCHIVIO PER LA CREAZIONE AUTOMATICA DI UNA SEQUENZA DI FOTO CHE RAPPRESENTA UNA STORIA EMOZIONALE DA STAMPARE E/O CONSERVARE 169
DERIVATI DI [(3-IDROSSI-4-PIRON-2-IL)METIL]-AMINA E LORO USO COME FARMACI ANTI-NEOPLASTICI 168
Derivato tetramerico dell'indol-3-carbinolo ad attività anticancerogena e metodo di sintesi del derivato stesso 166
USE OF ISOLATED MATURE ADIPOCYTES IN REGENERATIVE MEDICINE FOR THE RECONSTRUCTION AND REPARATION OF TISSUES 166
PREPARATION OF 3-UREIDO-2,4-DIOXOTETRAHYDRO-1,5-BENZODIAZEPINES AS CCK AND GASTRIN ANTAGONISTS 165
PREPARATION OF ANELLATED CARBAPENEMS AS ANTIBIOTICS 165
3,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(1H)-ONE DERIVATIVES 164
3-AMINO-4-CARBAMYLPYRROLE DERIVATIVES 163
Procedimento di valutazione automatica della qualità di foto digitali 163
PREPARATION AND TESTING OF N15-ALKYL AND N15,N15-DIALKYL DERIVATIVES OF TEICOPLANIN COMPOUNDS AS BACTERICIDES 162
PHARMACOLOGICALLY ACTIVE PYRROLODIAZEPINES 161
Derivati 1-Acilamminoalchilindolici come agonisti della melatonina. 160
Procedimento per la produzione di derivati t-butilati del cardanolo e del 3-n-pentadecilfenolo 159
Derivati fosforilati del cardanolo o del 3-n-pentadecilfenolo utili come additivi per lubrificanti e procedimento per la loro preparazione. 158
PREPARATION OF 13-DE(ACETAMIDOGLUPYRANOSYL)-34-DEOXYTEICOPLANIN DERIVATIVES AS ANTIBACTERIALS 156
Nanosfere polimeriche e relativo utilizzo per veicolare oligonucleotidi. 156
AMINOPYRROLE DERIVATIVES 155
PYRROLODIAZEPINE DERIVATIVES 154
PYRROLODIAZEPINES 154
PYRROLO[3,4-b]PYRIDINES 151
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 147
Preparation of 2-trichloroacetoxy-3,4,5,6-tetrachlorobenzoic acid and compositions containing same for treating benign mammalian neoformations. 145
Procedimento per la produzione di antiossidanti solforati da derivati dell'olio del guscio della noce di anacardio. 144
Nuovo procedimento per la raffinazione dell'olio derivato dai gusci delle noci di anacardio e prodotto ottenuto con tale procedimento. 144
Preparation of heterocyclic compounds as fluorescent probes for detection in biological systems 144
Methods, Compositions, and Other Compounds for Modulation of Monoacylglycerol Lipase Pain, and Stress-related Disorders 143
MACCHINA PER ANALISI CHIMICA COMPRENDENTE LA COMBINAZIONE DELLA SPETTROMETRIA DI MASSA A IONIZZAZIONE ELETTRONICA CON LA CROMATOGRAFIA LIQUIDA 143
PREPARATION OF DE(ACETYLGLUCOSAMINYL)DIDEHYDRODEOXYTEICOPLANIN DERIVATIVES AS ANTIBIOTICS 140
Manufacture of antioxidants for rubbers from phenolic pitch. 138
ANTIINFLAMMATORY 4,5-OXAZOLEDICARBOXAMIDES 138
Inhibitors of anandamide transport and their therapeutic use 135
Procedimento per la preparazione di derivati perfluorurati del cardanolo utili come intermedi organici, idrorepellenti, impregnanti, insetticidi, fitofarmaci e precursori di bisfenoli, resine fenoliche o resine fenoliche modificate. 134
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 132
Derivati del glutatione e loro utilizzi per il trattamento di malattie virali 132
PREPARATION OF 22-DECHLOROTEICOPLANIN AS ANTIBACTERIALS 127
Filter for the equalization and/or linearization of non-Linear systems 125
Preparation and anticancer activity of tetramerous deriv. of indole-3-carbinol. 125
Totale 25.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022981 0 0 146 244 29 8 34 59 88 44 13 316
2022/20232.093 253 177 137 225 152 482 8 173 266 45 123 52
2023/2024625 56 62 29 51 41 152 39 65 3 35 17 75
2024/20251.768 152 64 434 117 49 112 151 108 180 97 193 111
2025/20269.366 390 851 1.565 623 338 340 676 132 3.992 181 197 81
2026/2027380 107 104 169 0 0 0 0 0 0 0 0 0
Totale 26.247